AI Insight
A retrospective study found that individuals who used estrogen-only hormone therapy during menopause showed a reduced likelihood of developing dementia signs compared to those who did not receive this treatment. The research specifically examined estrogen-only therapy, distinguishing it from combination hormone therapies that include both estrogen and progestin. The findings suggest a potential protective effect of estrogen-only treatment against Alzheimer's disease and related dementias.
Why it matters
This research could influence treatment decisions for menopausal individuals, particularly those who have had hysterectomies and can safely use estrogen-only therapy. If confirmed through additional studies, it may provide a preventive strategy for reducing Alzheimer's risk in a specific population, though the retrospective nature means causation cannot be firmly established.
Understand the Science
In a retrospective study, people taking estrogen-only hormone therapy for menopause were less likely to see signs of dementia
Source: Estrogen-only hormone therapy could lower risk of Alzheimer’s